Background Published cases of iatrogenic cerebral amyloid angiopathy (iCAA) are increasing; however, their geographic ...
Background Information about the incidence of cerebral cavernous malformations (CCM) is sparse and the effect of increasing MRI availability is uncertain. Our objective was to assess the incidence of ...
Background The role of physical activity in the risk of amyotrophic lateral sclerosis (ALS) is debated. It is also unclear whether the association differs in people at high genetic risk of ALS.
3 Division of Clinical Neurosciences, University of Edinburgh, Edinburgh, UK Correspondence to Professor Rustam Al-Shahi Salman, Division of Clinical Neurosciences, University of Edinburgh, Western ...
10 Central and Peripheral Degenerative Neuropathy Unit, IRCCS Foundation, Carlo Besta Neurological Institute, Milan, Italy Background We reported that 6-month therapy with intravenous immunoglobulin ...
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be ...
Correspondence to Dr Fei Ma, Department of Epidemiology and Biostatistics, School of Public Health, Tianjin Medical University, Tianjin 300070, China; mf2002245mf{at}aliyun.com Background Higher ...
1 Brain and Mind Centre, Sydney Medical School, The University of Sydney, Sydney, New South Wales, Australia Lower motor neuron (LMN) syndromes typically present with muscle wasting and weakness and ...
1 Department of Neurology, Royal Victoria Infirmary, Newcastle upon Tyne, UK 2 Department of Neurophysiology, Royal Victoria Infirmary, Newcastle upon Tyne, UK 3 Department of Rheumatology, Royal ...
Background The ICE trial demonstrated the efficacy of immune globulin intravenous (IGIV-C) over placebo in chronic inflammatory demyelinating polyradiculoneuropathy (CIDP). However, improving the ...
Background Ocrelizumab, a monoclonal antibody targeting CD20+ B cells, is a high-efficacy therapy for multiple sclerosis (MS). Methods Patients with relapse-onset MS treated with ocrelizumab, ...
2 Department of Neurology, IRYCIS, Hospital Ramon y Cajal, Madrid, Spain 3 Department of Neurology, Hospital Fundacion Alcorcon, Madrid, Spain 4 Department of Neurology, Hospital Puerta de Hierro, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results